<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Over a 3 year period the R506Q mutation in the factor V (FV) FV:Q506 gene, FV, factor XII (FXII), prothrombin, protein C, protein S, antithrombin, <z:chebi fb="5" ids="28304">heparin</z:chebi> cofactor II, anticardiolipin antibodies and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) (Lp(a)) were measured in 32 infants and children with sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Heterozygous FV:Q506 (n=5), homozygous FV:Q506 (n=2), homozygous FXII deficiency (n=1), <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo> type I (n=5), <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo> type II (n=1), <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e> type I (n=1) increased Lp (a) (n=5), activated protein C-resistance without mutation in the FV gene (n=2), and increased anticardiolipin IgG antibodies (n=2) were diagnosed in the children investigated </plain></SENT>
<SENT sid="2" pm="."><plain>In a further two patients we found combinations of increased Lp(a) with moderate hyperhomocystinaemia and heterozygous <z:e sem="disease" ids="C0398621" disease_type="Disease or Syndrome" abbrv="">plasminogen deficiency</z:e> with heterozygous FXII deficiency </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, increased anticardiolipin IgG antibodies were found in combination with heterozygous FV:Q506 (n=1) and protein C type I deficiency (n=2) respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Out of 32 patients with venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp>, 3 showed additional peripheral venous <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Contributing factors were present in 31 out of 32 patients investigated </plain></SENT>
<SENT sid="6" pm="."><plain>Family members of 10 affected children had suffered from venous thrombo-embolism prior to the study </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our data suggest that additional contributing factors may promote manifestation of cerebral venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> in infants and children with an inherited prothrombotic state </plain></SENT>
<SENT sid="8" pm="."><plain>Further prospective studies are required to evaluate their potential role as "triggering" agents </plain></SENT>
</text></document>